The epidemiology of the systemic inflammatory response syndrome

Current Opinion in Infectious Diseases

Volumn 9, Issue 4, 1996, Pages 261-264

  Jeljaszewicz, Janusz ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INFECTION; INFLAMMATION; SEPSIS; SEPTIC SHOCK; SHORT SURVEY; SYNDROME;

EID: 0029811919     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199608000-00010     Document Type: Short Survey

References (19)

1. Rangel-Frauusto MS, Pittet D, Costigan M, Hwant T, Davis CS, Wenzel •• RP: The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995, 273:117-123. A most important paper in the literature of SIRS and associated phenomena. The first description based on a solid clinical investigation, and basis for the epidemiology, of SIRS.
2. American College of Chest Physicians - Society of Critical Care Consensus Conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-875.
3. Sasse KC, Nauenberg E, Long A, Anton B, Tucker HJ, Hu T: Long-term • survival after intensive care unit admission with sepsis. Crit Care Med 1995, 23:1040-1047. A good prospective study of severe sepsis with a follow-up.
4. Baker CC, Huynh T: Sepsis in the critically ill patient. Curr Probl Surg •• 1995, 32:1013-1092. This paper contains detailed information about sepsis and is a very good reference source with appropriate interpretation.
5. Marshall JC, Christou NV, Meakins JL: The gastrointestinal tract - the 'undrained abscess' of multiple organ failure. Ann Surg 1993, 218:111-119.
6. Yao YM, Bahrami S, Leichtfried G, Redl H, Schlag G: Pathogenesis of • hemorrhage - induced bacterial endotoxin translocation in rats. Effects of recombinant bactericidal permeability increasing protein. Ann Surg 1995, 221:398-405. An experimental demonstration of the effect of bactericidal/permeability-increasmg protein on bacterial translocation in the development of shock.
7. Dentener MA, Von Asmuth EJ, Francot GJ: Antagonistic effect of lipopolysaccharide-binding protein and bactericidal permeability-increasing protein on lipopolysaccharide induced cytokine release by mononuclear phagocytes competition for binding to lipopolysaccharide. J Immunol 1993, 151:4258-4265.
8. Meszaros K, Aberle S, Decknk R: Monocyte tissue factor induction by LPS. Dependence on LPS binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability increasing protein. Blood 1994, 83:2516-2525.
9. Ammons WS, Kung H: Recombinant amino terminal fragment of bactericidal/permeability increasing protein prevents hemodynamic responses to endotoxin. Circ Shock 1993, 41:176-184.
10. Kohn R, Ammons WS, Horwitz A: Protective effect of a recombinant amino terminal fragment of bactericidal/ permeability increasing protein in experimental endotoxemia. J Infect Dis 1993, 188:1307-1310.
11. Purvis D, Kirby R: Systemic inflammatory response syndrome - septic shock. Vet Clin N Am 1994, 24:1225-1247.
12. Eisenman A, Baruch Y, Shechter, Oren I: Blood exchange - a rescue procedure for complicated falciparum malaria. Vox Sang 1995. 68:19-21
13. Fujishima S, Aikawa N: Neutrophil-mediated tissue injury and its modulation. Intens Care Med 1995, 21:277-285. An explanation of SIRS/MODS in the lung. and of the participation of neutrophils.
14. Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A, Tran T, Whiteside T: • Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. JAMA 1995, 274:58-65. A demonstration of SIRS in association with liver cirrhosis, and of the role of leukocytes.
15. Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW: Myocardial •• contractile dysfunction in the systemic inflammatory response syndrome - role of cytokine inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 1995, 27:155-167. Important results on possible cardiac mechanism of SIRS.
16. Pixley RA, Zellis S, Bankes P, DeLa Cadena RA, Page D, Scott CF. • Kappelmayer J. Wyshock EG, Kelly JJ, Colman RW: Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome. Crit Care Med 1995, 23:41-51. Valuable indications regarding the participation of clotting and fibnnolysis systems.
17. Herfarth C, Schumpelick V, Siewert JR: Sepsis-sepsis syndrome - systemic inflammatory response syndrome [Editorial] [In German] Chirurg 1995, 66:1.
18. Bone C: Sepsis, sepsis syndrome, and the systemic inflammatory •• response syndrome (SIRS) [Editorial]. JAMA 1995, 273:155-156. A very intelligent comment on the present status of knowledge.
19. Wenzel RP: Anti-endotoxin monoclonal antibodies: a second look. New Engl J Med 1992, 326:1151-1153.